This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pricing & Contracting USA 2024
May 21-23, 2024
Delivered as a Hybrid EventHilton New Orleans Riverside, New Orleans, LA

Katie Verb, JD
Senior Director, Executive Branch Strategy, U.S. Policy & Government Affairs at Bristol Myers Squibb


Katie Verb is currently the Senior Director of the Executive Branch Strategy team at Brystol Myers Squibb. In this role, she leads a policy team working on issues across the health care system include IRA implementation, Medicare, 340B, and PBM reform. Prior to this role, Katie was the Head of Public Policy at Horizon Therapeutics where she led a team handling reimbursement and coverage policy across all payers, as well as FDA regulatory policy. As a Director of Policy & Research at PhRMA, Katie worked on Medicare Part B, biosimilars, and cell & gene therapy policy. Prior to that, Katie led the Government Affairs team at the Hemophilia Federation of America, dealing with access, safety, and coverage issues that impact the rare disease community. Katie has a J.D. from Michigan State University and a Bachelors from Loyola University Chicago.

Agenda Sessions

  • Closed Door (Manufacturers Only) Exploring Unacknowledged Effects of 340B and State Ramifications